Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jan;16(1):17-24.
doi: 10.1016/j.cardfail.2009.08.008. Epub 2009 Oct 7.

The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design

David A Kass  1 , Dalane W Kitzman, Guy E Alvarez
Affiliations
Randomized Controlled Trial

The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design

David A Kass et al. J Card Fail. 2010 Jan.

Abstract

Background: Heart failure with preserved ejection fraction (HFpEF) is the predominant form of heart failure among the elderly and in women. However, there are few if any evidence-based therapeutic options for HFpEF. The chief complaint of HFpEF is reduced tolerance to physical exertion. Recent data revealed that 1 potential mechanism of exertional intolerance in HFpEF patients is inadequate chronotropic response. Although there is considerable evidence demonstrating the benefits of rate-adaptive pacing (RAP) provided from implantable cardiac devices in patients with an impaired chronotropic response, the effect of RAP in HFpEF is unknown.

Methods and results: The Restoration of Chronotropic CompEtence in Heart Failure PatientS with Normal Ejection FracTion (RESET) study is a prospective, multicenter, double-blind, randomized with stratification, study assessing the effect of RAP on peak oxygen consumption and quality of life. RAP therapy will be evaluated in a crossover paired fashion for each patient within each study stratum. Study strata are based on patient beta-blocker usage at time of enrollment. The study is powered to assess the impact of pacing independently in both strata.

Conclusions: The RESET study seeks to evaluate the potential benefit of RAP in patients with symptomatic mild to moderate HFpEF and chronotropic impairment. Study enrollment began in July 2008.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Drs. Kass and Kitzman have received honoraria as consultants from Boston Scientific CRM. Dr. Alvarez is an employee of Boston Scientific CRM.

Figures

Figure
Figure
RESET Study schema. Patients satisfying the inclusion and exclusion criteria are stratified according to beta-blocker usage then progress to the screening visit for implant eligibility testing. Pacing therapy will be evaluated within each stratum in all implanted patients during the one month visits A and B in a randomized fashion. Upon completion of the one month visits, pacing therapy will be active in all patients in each stratum for the duration of the study. βB + or −, with or without beta-blocker; CPX, cardiopulmonary exercise test; CI, chronotropic incompetence; EF, left ventricular ejection fraction; QoL, quality of life; R, within strata randomized cross-over; mo. = 1, 6, 12 month patient follow-up visits respectively; RAP, rate-adaptive pacing; EoS, end of study.
See this image and copyright information in PMC

References

    1. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003 May 15;348(20):2007–2018. - PubMed
    1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 Jan 29;117(4):e25–146. - PubMed
    1. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. Jama. 2006 Nov 8;296(18):2209–2216. - PubMed
    1. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001 Feb 15;87(4):413–419. - PubMed
    1. Redfield MM, Jacobsen SJ, Burnett JC, Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. Jama. 2003 Jan 8;289(2):194–202. - PubMed

Publication types

LinkOut - more resources